AccuMed, Inc. Sustainability Profile
AccuMed, Inc., a leading name in the medical technology industry, is headquartered in the United States and operates across various regions, providing innovative solutions in healthcare. Founded in the early 2000s, the company has achieved significant milestones, establishing itself as a trusted provider of advanced medical devices and diagnostic tools. AccuMed's core offerings include precision measurement instruments and health monitoring systems, distinguished by their accuracy and user-friendly design. The company’s commitment to quality and innovation has positioned it favourably in the competitive landscape, earning accolades for its contributions to patient care and safety. With a focus on enhancing healthcare outcomes, AccuMed continues to set benchmarks in the industry, making it a preferred choice for healthcare professionals worldwide.
DitchCarbon Score
How does AccuMed, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
AccuMed, Inc.'s score of 31 is higher than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
AccuMed, Inc., headquartered in the US, currently does not have specific carbon emissions data available, as indicated by the absence of reported emissions figures. The company is a current subsidiary of Medline Industries, Inc., and any potential emissions data or climate commitments may be inherited from this parent organisation. As of now, AccuMed, Inc. has not established any documented reduction targets or commitments to the Science Based Targets initiative (SBTi). The lack of specific climate pledges or reduction initiatives suggests that the company may still be in the early stages of developing its sustainability strategy. Given the context of its parent company, Medline Industries, Inc., it is important to note that any climate-related initiatives or performance metrics would likely be influenced by the broader corporate family’s sustainability goals. However, without specific data or commitments from AccuMed, Inc., it is challenging to provide a detailed overview of its carbon emissions and climate commitments.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2016 | 2017 | 2019 | 2020 | 2021 | 2023 | |
|---|---|---|---|---|---|---|
| Scope 1 | 45,201,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 |
| Scope 2 | 81,309,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 |
| Scope 3 | 90,611,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 |
How Carbon Intensive is AccuMed, Inc.'s Industry?
How Carbon Intensive is AccuMed, Inc.'s Location?
AccuMed, Inc.'s Scope 3 Categories Breakdown
AccuMed, Inc.'s Scope 3 emissions, which increased significantly last year and increased significantly since 2016, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 81% of Scope 3 emissions.
Top Scope 3 Categories
AccuMed, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
AccuMed, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
